Takeda Pharmaceutical Co., Ltd. (TAK)
16.61
+0.04
(+0.24%)
USD |
NYSE |
May 19, 12:07
Takeda Pharmaceutical Total Assets (Quarterly) : 97.13B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Sanofi | -- |
| Eli Lilly & Co. | 116.58B |
| AstraZeneca PLC | 114.02B |
| Johnson & Johnson | 200.89B |
| Novo Nordisk A/S | 86.23B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 48.26B |
| Shareholders Equity (Quarterly) | 48.86B |
| Debt to Equity Ratio | 0.628 |
| Current Ratio | 1.272 |
| Net Debt Paydown Yield | 0.04% |